EBR:BTLS • BE0974386188
ChartMill assigns a Buy % Consensus number of 87% to BTLS.BR. The Buy consensus is the weighted average rating of the current analysts ratings.
9 analysts have analysed BTLS.BR and the average price target is 8.02 EUR. This implies a price increase of 181.54% is expected in the next year compared to the current price of 2.85.
The consensus rating for BIOTALYS NV (BTLS.BR) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.